Bi Li-Ming, Chen Ying-Lan, Chen Ya-Feng, Zhu Dong-Yun, Lu Shu, Feng Dian-Xu
Putuo Clinical Medical College Affiliated Shanghai University of Traditional Chinese Medicine, Shanghai 200062, China.
Department of Nephrology, Wuxi Hospital of Chinese Medicine, Wuxi 214071, China.
Zhongguo Zhong Yao Za Zhi. 2018 Jun;43(12):2470-2473. doi: 10.19540/j.cnki.cjcmm.20180115.001.
There are 400 thousand patients with long-term hemodialysis in China nowadays. Hemodialysis, as the most common alternative to renal replacement therapy, prolongs the life span of patients with end stage renal failure. However, there are still many complications of hemodialysis treatment. These complications reduce the quality of life of patients and may even endanger their life, and sometimes they are difficult to deal with. Classical prescriptions, commonly referred to as classical effective prescriptions in modern medicine, mainly indicating the formulas recorded in Treatise on Febrile Diseases and Synopsis of Golden Chamber, were relative to contemporary prescriptions emerging after Song and Yuan dynasties. Prescriptions corresponding to syndromes means one-to-one correspondence between syndromes and prescriptions, with many advantages and that is the key of clinical efficacy. Many complications of hemodialysis patients have typical clinical manifestations, which can match the syndromes corresponding to classical prescriptions, thus quickly relieving the symptoms of patients in clinical application. Six clinical cases of dialysis muscle spasm, disequilibrium syndrome, restless legs syndrome, uremic encephalopathy, post dialysis arrhythmia, and secondary hyperparathyroidism were used in this paper, to explore the intervention strategies for hemodialysis related complications.
目前中国有40万长期血液透析患者。血液透析作为肾脏替代治疗最常见的方式，延长了终末期肾衰竭患者的寿命。然而，血液透析治疗仍存在许多并发症。这些并发症降低了患者的生活质量，甚至可能危及生命，而且有时难以处理。经方，在现代医学中通常称为经典有效方剂，主要指《伤寒论》和《金匮要略》中记载的方剂，与宋、元之后出现的时方相对。方证对应是指证候与方剂的一一对应，具有诸多优势，是临床疗效的关键。血液透析患者的许多并发症具有典型的临床表现，可与经方对应的证候相匹配，从而在临床应用中迅速缓解患者症状。本文采用了6例透析中肌肉痉挛、失衡综合征、不安腿综合征、尿毒症脑病、透析后心律失常和继发性甲状旁腺功能亢进的临床病例，探讨血液透析相关并发症的干预策略。
